作为结核病新型诊断生物标志物和免疫调节器的ANKRD22:多队列和临床验证研究
Qing-Qing Shan1, Meng Luo2, YongXian Zhang1
1Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China; State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Sichuan University, Chengdu, 610041, China.
The Journal of infection
|February 17, 2026
概括
ANKRD22是诊断结核病 (TB) 的有希望的生物标志物. 它的高水平与免疫抑制环境相关,表明有针对性治疗的潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 生物标志物发现发现
- 传染性疾病 传染性疾病
背景情况:
- 结核病 (TB) 是一个重大的全球卫生挑战.
- 在转录组研究中,ANKRD22被确定为潜在的生物标志物.
- 在结核病中ANKRD22的诊断和功能意义需要进一步调查.
研究的目的:
- 评估ANKRD22作为活跃结核病的诊断生物标志物.
- 研究ANKRD22在结核病免疫微环境中的功能作用.
主要方法:
- 对23个公开的转录组数据集和一个临床队列的分析.
- 使用RT-qPCR对ANKRD22表达的量化.
- 通过ROC分析和与免疫细胞透和通路的相关性来评估诊断性能.
主要成果:
- 在活跃的结核病患者中,ANKRD22表达显著上调,随着疾病的严重程度而增加,并在治疗后下降.
- ANKRD22显示出强大的诊断准确性 (数据集中的AUC为0.709-0.986,临床样本中的AUC为0.855).
- 高ANKRD22与免疫抑制环境相关,包括增加的中性粒细胞,巨细胞,调节性T细胞,MDSC和减少的NK细胞,以及在体外减弱的M2巨细胞两极分化.
结论:
- ANKRD22 作为活跃结核病的潜在诊断生物标志物.
- 在结核病中,ANKRD22与免疫抑制性免疫微环境有关.
- 这些发现支持ANKRD22在结核病诊断中的实用性以及对宿主导向治疗策略的潜力.
相关概念视频
Pulmonary Tuberculosis IV
557
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
557
Pulmonary Tuberculosis II
1.7K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.7K
Pulmonary Tuberculosis I
1.0K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.0K
Pulmonary Tuberculosis III
1.1K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.1K


